Resistance to immune checkpoint inhibitors in gastric cancer

被引:13
作者
Liu, Kai [1 ]
Yuan, Shiman [1 ]
Wang, Chenyu [2 ]
Zhu, Hong [3 ]
机构
[1] Guizhou Med Univ, Clin Med Coll, Guiyang, Peoples R China
[2] Lanzhou Univ, Clin Med Coll 2, Lanzhou, Peoples R China
[3] Sichuan Univ, West China Hosp, Canc Ctr, Dept Med Oncol, Chengdu 610000, Peoples R China
关键词
immunotherapy resistance; mechanism; immune checkpoint inhibitor; gastric cancer; tumor microenvironment; LIGAND; 1; EXPRESSION; TUMOR-ASSOCIATED MACROPHAGES; REGULATORY T-CELLS; SUPPRESSOR-CELLS; ANTI-PD-1; THERAPY; MUTATIONAL BURDEN; PD-L1; GROWTH-FACTOR; B7; FAMILY; ESOPHAGEAL;
D O I
10.3389/fphar.2023.1285343
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gastric cancer (GC) is one of the most common gastrointestinal malignancies worldwide. In the past decade, with the development of early diagnostic techniques, a clear decline in GC incidence has been observed, but its mortality remains high. The emergence of new immunotherapies such as immune checkpoint inhibitors (ICIs) has changed the treatment of GC patients to some extent. However, only a small number of patients with advanced GC have a durable response to ICI treatment, and the efficacy of ICIs is very limited. Existing studies have shown that the failure of immunotherapy is mainly related to the development of ICI resistance in patients, but the understanding of the resistance mechanism is still insufficient. Therefore, clarifying the mechanism of GC immune resistance is critical to improve its treatment and clinical benefit. In this review, we focus on summarizing the mechanisms of primary or acquired resistance to ICI immunotherapy in GC from both internal and external aspects of the tumor. At the same time, we also briefly discuss some other possible resistance mechanisms in light of current studies.
引用
收藏
页数:15
相关论文
共 141 条
[31]   Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers [J].
Goodman, Aaron M. ;
Kato, Shumei ;
Bazhenova, Lyudmila ;
Patel, Sandip P. ;
Frampton, Garrett M. ;
Miller, Vincent ;
Stephens, Philip J. ;
Daniels, Gregory A. ;
Kurzrock, Razelle .
MOLECULAR CANCER THERAPEUTICS, 2017, 16 (11) :2598-2608
[32]   Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients [J].
Gopalakrishnan, V. ;
Spencer, C. N. ;
Nezi, L. ;
Reuben, A. ;
Andrews, M. C. ;
Karpinets, T. V. ;
Prieto, P. A. ;
Vicente, D. ;
Hoffman, K. ;
Wei, S. C. ;
Cogdill, A. P. ;
Zhao, L. ;
Hudgens, C. W. ;
Hutchinson, D. S. ;
Manzo, T. ;
de Macedo, M. Petaccia ;
Cotechini, T. ;
Kumar, T. ;
Chen, W. S. ;
Reddy, S. M. ;
Sloane, R. Szczepaniak ;
Galloway-Pena, J. ;
Jiang, H. ;
Chen, P. L. ;
Shpall, E. J. ;
Rezvani, K. ;
Alousi, A. M. ;
Chemaly, R. F. ;
Shelburne, S. ;
Vence, L. M. ;
Okhuysen, P. C. ;
Jensen, V. B. ;
Swennes, A. G. ;
McAllister, F. ;
Sanchez, E. Marcelo Riquelme ;
Zhang, Y. ;
Le Chatelier, E. ;
Zitvogel, L. ;
Pons, N. ;
Austin-Breneman, J. L. ;
Haydu, L. E. ;
Burton, E. M. ;
Gardner, J. M. ;
Sirmans, E. ;
Hu, J. ;
Lazar, A. J. ;
Tsujikawa, T. ;
Diab, A. ;
Tawbi, H. ;
Glitza, I. C. .
SCIENCE, 2018, 359 (6371) :97-103
[33]   Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade [J].
Gu, Shengqing Stan ;
Zhang, Wubing ;
Wang, Xiaoqing ;
Jiang, Peng ;
Traugh, Nicole ;
Li, Ziyi ;
Meyer, Clifford ;
Stewig, Blair ;
Xie, Yingtian ;
Bu, Xia ;
Manos, Michael P. ;
Font-Tello, Alba ;
Gjini, Evisa ;
Lako, Ana ;
Lim, Klothilda ;
Conway, Jake ;
Tewari, Alok K. ;
Zeng, Zexian ;
Das Sahu, Avinash ;
Tokheim, Collin ;
Weirather, Jason L. ;
Fu, Jingxin ;
Zhang, Yi ;
Kroger, Benjamin ;
Liang, Jin Hua ;
Cejas, Paloma ;
Freeman, Gordon J. ;
Rodig, Scott ;
Long, Henry W. ;
Gewurz, Benjamin E. ;
Hodi, F. Stephen ;
Brown, Myles ;
Liu, X. Shirley .
CANCER DISCOVERY, 2021, 11 (06) :1524-1541
[34]   Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy [J].
Gutwillig, Amit ;
Santana-Magal, Nadine ;
Farhat-Younis, Leen ;
Rasoulouniriana, Diana ;
Madi, Asaf ;
Luxenburg, Chen ;
Cohen, Jonathan ;
Padmanabhan, Krishnanand ;
Shomron, Noam ;
Shapira, Guy ;
Gleiberman, Annette ;
Parikh, Roma ;
Levy, Carmit ;
Feinmesser, Meora ;
Hershkovitz, Dov ;
Zemser-Werner, Valentina ;
Zlotnik, Oran ;
Kroon, Sanne ;
Hardt, Wolf-Dietrich ;
Debets, Reno ;
Reticker-Flynn, Nathan Edward ;
Rider, Peleg ;
Carmi, Yaron .
ELIFE, 2022, 11
[35]   Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma [J].
Harada, Kazuto ;
Dong, Xiaochuan ;
Estrella, Jeannelyn S. ;
Correa, Arlene M. ;
Xu, Yan ;
Hofstetter, Wayne L. ;
Sudo, Kazuki ;
Onodera, Hisashi ;
Suzuki, Koyu ;
Suzuki, Akihiro ;
Johnson, Randy L. ;
Wang, Zhenning ;
Song, Shumei ;
Ajani, Jaffer A. .
GASTRIC CANCER, 2018, 21 (01) :31-40
[36]   The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment [J].
Hayes, Conall ;
Donohoe, Claire L. ;
Davern, Maria ;
Donlon, Noel E. .
CANCER LETTERS, 2021, 500 :75-86
[37]   Gastric cancer cells alter the immunosuppressive function of neutrophils [J].
Hiramatsu, Soichiro ;
Tanaka, Hiroaki ;
Nishimura, Junya ;
Yamakoshi, Yoshihito ;
Sakimura, Chie ;
Tamura, Tatsuro ;
Toyokawa, Takahiro ;
Muguruma, Kazuya ;
Yashiro, Masakazu ;
Hirakawa, Kosei ;
Ohira, Masaichi .
ONCOLOGY REPORTS, 2020, 43 (01) :251-259
[38]   Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses [J].
Ho, Ping-Chih ;
Bihuniak, Jessica Dauz ;
Macintyre, Andrew N. ;
Staron, Matthew ;
Liu, Xiaojing ;
Amezquita, Robert ;
Tsui, Yao-Chen ;
Cui, Guoliang ;
Micevic, Goran ;
Perales, Jose C. ;
Kleinstein, Steven H. ;
Abel, E. Dale ;
Insogna, Karl L. ;
Feske, Stefan ;
Locasale, Jason W. ;
Bosenberg, Marcus W. ;
Rathmell, Jeffrey C. ;
Kaech, Susan M. .
CELL, 2015, 162 (06) :1217-1228
[39]   Targeting the epigenetic regulation of antitumour immunity [J].
Hogg, Simon J. ;
Beavis, Paul A. ;
Dawson, Mark A. ;
Johnstone, Ricky W. .
NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (11) :776-800
[40]   Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer [J].
Huang, Ruea-Yea ;
Francois, Ariel ;
McGray, A. J. Robert ;
Miliotto, Anthony ;
Odunsi, Kunle .
ONCOIMMUNOLOGY, 2017, 6 (01)